FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing enasidenib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tafasitamab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tafasitamab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only tafasitamab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tafasitamab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only enzalutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Enzalutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing enzalutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely enzalutamide 40 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing enzalutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing exemestane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only exemestane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Exemestane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely exemestane 25 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing exemestane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing erdafitinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only erdafitinib (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only etoglucid (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing etoglucid (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pomalidomide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only pomalidomide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing pomalidomide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pomalidomide 1 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pomalidomide 2 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pomalidomide 4 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing pomalidomide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only picoplatin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing picoplatin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only plevitrexed (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing plevitrexed Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing moxetumomab pasudotox (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only moxetumomab pasudotox (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Testolactone Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only testolactone in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely testolactone 50 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing testolactone Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing testolactone in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tasonermin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing tasonermin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only zanolimumab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing zanolimumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing belantamab mafodotin (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Belantamab mafodotin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing belantamab mafodotin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing trastuzumab emtansine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab emtansine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only trastuzumab emtansine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing razoxane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Razoxane Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only razoxane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing razoxane in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only oregovomab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing oregovomab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nafoxidine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nafoxidine (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only naptumomab (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing naptumomab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nilutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only nilutamide (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely nilutamide 150 milligram/1 each conventional release oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nilutamide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing nilutamide in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing obinutuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing obinutuzumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only obinutuzumab in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Obinutuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing alemtuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alemtuzumab Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing arsenic trioxide Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only arsenic trioxide (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only abemaciclib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing abemaciclib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing abemaciclib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Abemaciclib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only acalabrutinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing acalabrutinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing acalabrutinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Acalabrutinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing alitretinoin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alitretinoin Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing altretamine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only altretamine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely altretamine 50 milligram/1 each conventional release oral capsule Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing altretamine in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Altretamine Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing belinostat in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only belinostat in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely belinostat 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing belinostat Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only belinostat (medicinal product) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bosutinib Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing only bosutinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Product containing bosutinib in oral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 11 of 26 Next End

This concept is not in any reference sets

Back to Start